About: Incidence and clinical profiles of COVID-19 pneumonia in pregnant women: A single-centre cohort study from Spain

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Incidence and clinical profiles of COVID-19 pneumonia in pregnant women: A single-centre cohort study from Spain Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Incidence and clinical profiles of COVID-19 pneumonia in pregnant women: A single-centre cohort study from Spain
Creator	Silva, Tiago Folgueira, Dolores Lalueza, Antonio Lumbreras, Carlos Aguado, María Barbero, Patricia Batllori, Emma Corbella, Laura Fern Andez-Ruiz, Mario Forc En, Laura Galindo, Alberto García-Burguillo, Antonio Hern Andez-Jim Enez, Pilar L Opez-Medrano, Francisco Lizaso, Manuel Mejía, Inma Rodríguez-Goncer, Isabel Ruiz-Ruig Omez, María San-Juan, Rafael
Source	Elsevier; Medline; PMC
abstract	BACKGROUND: Information regarding the incidence and characteristics of COVID-19 pneumonia amongst pregnant women is scarce. METHODS: Single-centre experience with 32 pregnant women diagnosed with COVID-19 between March 5 to April 5, 2020 at Madrid, Spain. FINDINGS: COVID-19 pneumonia was diagnosed in 61·5% (32/52) women. Only 18·7% (6/32) had some underlying condition (mostly asthma). Supplemental oxygen therapy was required in 18 patients (56·3%), with high-flow requirements in six (18·7%). Eight patients (25·0%) fulfilled the criteria for acute distress respiratory syndrome. Invasive mechanical ventilation was required in two patients (6·2%). Tocilizumab was administered in five patients (15·6%). Delivery was precipitated due to COVID-19 in three women (9·4%). All the newborns had a favourable outcome, with no cases of neonatal SARS-CoV-2 transmission. Severe cases of pneumonia requiring supplemental oxygen were more likely to exhibit bilateral alveolar or interstitial infiltrates on chest X-ray (55·6% vs. 0·0%; P-value = 0·003) and serum C-reactive protein (CRP) levels >10 mg/dL (33·0% vs. 0·0%; P-value = 0·05) at admission than those with no oxygen requirements. INTERPRETATION: Pregnant women with COVID-19 have a high risk of developing pneumonia, with a severe course in more than half of cases. The presence of bilateral kung infiltrates and elevated serum CRP at admission may identify women at-risk of severe COVID-19 pneumonia. FUNDING: Instituto de Salud Carlos III (COV20/00,181), Spanish Ministry of Science and Innovation.
has issue date	2020-06-15(xsd:dateTime)
bibo:doi	10.1016/j.eclinm.2020.100407
bibo:pmid	32632417
has license	no-cc
sha1sum (hex)	93d20c2bfa61af699ba5fbe758f09f94036b508e
schema:url	https://doi.org/10.1016/j.eclinm.2020.100407
resource representing a document's title	Incidence and clinical profiles of COVID-19 pneumonia in pregnant women: A single-centre cohort study from Spain
has PubMed Central identifier	PMC7295514
has PubMed identifier	32632417
schema:publication	EClinicalMedicine
resource representing a document's body	covid:93d20c2bfa61af699ba5fbe758f09f94036b508e#body_text
is schema:about of	named entity 'Spain' named entity 'pregnant women' named entity 'Spain' named entity 'La Jolla' named entity 'impaired liver function' named entity 'respiratory function' named entity 'pregnant women' named entity 'Obstetrics' named entity 'computerized tomography (CT) scan' named entity 'pregnant women' named entity 'oxygen' named entity 'supplemental oxygen' named entity 'COVID' named entity 'pneumonia' named entity 'Cough' named entity 'immunomodulatory drugs' named entity 'pregnant women' named entity 'URTI' named entity 'nasopharyngeal swab' named entity 'RT-PCR' named entity 'tocilizumab' named entity 'URTI' named entity 'COVID-19' named entity 'gastrointestinal symptoms' named entity '1, 2' named entity 'pneumonia' named entity 'pregnant women' named entity 'AST' named entity 'supplemental oxygen' named entity 'COVID' named entity 'lopinavir/ritonavir' named entity 'pneumonia' named entity 'persistent cough' named entity 'pneumonia' named entity 'ICU' named entity 'COVID-19' named entity 'coronavirus' named entity 'retrospective cohort study' named entity 'pneumonia' named entity 'antibiotics' named entity 'COVID' named entity 'Madrid' named entity 'COVID' named entity 'alveolar' named entity 'pregnant women' named entity 'caesarean section' named entity 'pneumonia' named entity 'COVID-19' named entity 'oseltamivir' named entity 'systemic inflammation' named entity 'pneumonia' named entity 'Supplemental oxygen' named entity 'fatigue' named entity 'respiratory symptoms' named entity 'pregnant women' named entity 'pregnant women' named entity 'SARS-CoV-2' named entity 'ordinal scale' named entity 'alveolar' named entity 'COVID' named entity 'Observational Studies' named entity 'acute respiratory distress syndrome' named entity 'obstetric'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software